BSEInsider Trading / SAST26 Sept 2026 · 26 Sept 2026, 07:23 pm
Closure of Trading Window
Ganga Pharmaceuticals Ltd · 539680
✦ AI SummaryResults
Ganga Pharmaceuticals Ltd has announced the closure of its trading window from October 1, 2026, for all designated persons due to the upcoming declaration of unaudited financial results for the half year ending September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ganga Pharmaceuticals Ltd - 539680 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
771d52c2-e384-4ae6-875f-2dd8b3e3b6bc.pdf
View document text
Ganga Pharmaceuticals Limited
CIN: L99999MH1989PLC053392
Regd. Office: Gangatat, Dhanvantri Marg, Gopcharpada, Virar (E), Palghar - 401305
Phone: 7620876456 |Website: www.ayurvedganga.com. | Email: ayurvedganga@gmail.com.
September 26, 2026
BSE Limited,
Phiroze Jeejeebhoy Towers,
Dalal Street, Fort,
Mumbai - 400001
Scrip Code: 539680
Subject: Intimation of Closure of Trading Window
Dear Sir/Madam,
Pursuant to Company’s Code of Conduct for prevention of Insider Trading, the
Trading Window for dealing in the Company's Shares will remain closed from
Thursday, October 01, 2026, for all Designated Persons of the Company.
The closure is in connection with the declaration of Un-audited Financial Results of
the Company for the half year ending on September 30, 2026.
The Trading Window will open 48 hours after the said financial results are declared
to the Stock Exchange.
Kindly take the same on your record.
Thanking You,
Yours faithfully,
For Ganga Pharmaceuticals Limited
Bharat Sharma
Managing Director
DIN: 00077026
Email ID: bharat.sharma@gangapharma.in